OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng, Sylvia H. Ley, Frank B. Hu
Nature Reviews Endocrinology (2017) Vol. 14, Iss. 2, pp. 88-98
Open Access | Times Cited: 4462

Showing 1-25 of 4462 citing articles:

Gut microbiota in human metabolic health and disease
Yong Fan, Oluf Pedersen
Nature Reviews Microbiology (2020) Vol. 19, Iss. 1, pp. 55-71
Open Access | Times Cited: 3115

Pathophysiology of Type 2 Diabetes Mellitus
Unai Galicia-García, Asier Benito‐Vicente, Shifa Jebari, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6275-6275
Open Access | Times Cited: 2055

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Griselda A. Cabral-Pacheco, Idalia Garza‐Veloz, Claudia Castruita-De la Rosa, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9739-9739
Open Access | Times Cited: 1110

Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora, Ruth C. R. Meex, Koen Venema, et al.
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 5, pp. 261-273
Open Access | Times Cited: 1094

Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Décio L. Eizirik, Lorenzo Pasquali, Miriam Cnop
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 7, pp. 349-362
Closed Access | Times Cited: 610

Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues
Estefanía Burgos‐Morón, Zaida Abad‐Jiménez, A Marañón, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1385-1385
Open Access | Times Cited: 460

Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
Casper G. Schalkwijk, Coen D.A. Stehouwer
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 407-461
Open Access | Times Cited: 429

Neutrophils in chronic inflammatory diseases
Andrea Herrero-Cervera, Oliver Soehnlein, Ellinor Kenne
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 177-191
Open Access | Times Cited: 369

Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
Jasvinder Singh Bhatti, Abhishek Sehrawat, Jayapriya Mishra, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 114-134
Open Access | Times Cited: 344

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 330

Screening for Prediabetes and Type 2 Diabetes
Karina W. Davidson, Michael J. Barry, Carol M. Mangione, et al.
JAMA (2021) Vol. 326, Iss. 8, pp. 736-736
Open Access | Times Cited: 317

The Role of the Pentose Phosphate Pathway in Diabetes and Cancer
Tongxin Ge, Jiawen Yang, Shihui Zhou, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 314

The role of the gut microbiome and its metabolites in metabolic diseases
Jiayu Wu, Kai Wang, Xuemei Wang, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 360-373
Open Access | Times Cited: 311

Emerging Targets in Type 2 Diabetes and Diabetic Complications
Sevgican Demir, Peter P. Nawroth, Stephan Herzig, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 305

Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention
Yan Liu, Yao Wang, Yueqiong Ni, et al.
Cell Metabolism (2019) Vol. 31, Iss. 1, pp. 77-91.e5
Open Access | Times Cited: 295

Diabetes Fact Sheet in Korea 2021
Jae Hyun Bae, Kyungdo Han, Seung‐Hyun Ko, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 3, pp. 417-426
Open Access | Times Cited: 269

Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Vicente Javier Clemente‐Suárez, Ana Isabel Beltrán-Velasco, Laura Redondo-Flórez, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2749-2749
Open Access | Times Cited: 268

Artificial Intelligence: The Future for Diabetes Care
Samer Ellahham
The American Journal of Medicine (2020) Vol. 133, Iss. 8, pp. 895-900
Closed Access | Times Cited: 266

Anthocyanin Pigments: Beyond Aesthetics
Bindhu Alappat, Jayaraj Alappat
Molecules (2020) Vol. 25, Iss. 23, pp. 5500-5500
Open Access | Times Cited: 259

Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Chen Li, Yu‐Qing Ni, Hui Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 255

Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Boju Sun, Li Wu, You Wu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 225

Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1‐Foxo1 and PI3K‐Akt signalling pathways
Bincheng Ren, Yu‐fei Zhang, Shanshan Liu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 21, pp. 12355-12367
Open Access | Times Cited: 225

Interaction of dietary polyphenols and gut microbiota: Microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health
Gizem Çatalkaya, Koen Venema, Luigi Lucini, et al.
Food Frontiers (2020) Vol. 1, Iss. 2, pp. 109-133
Open Access | Times Cited: 223

Page 1 - Next Page

Scroll to top